- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06534593
Effects of Physical Therapy on Low Back Pain, Disc Height Index, Postural Stability, Disability, Gait and Function in Persons With Postero-lateral Disc Herniation (DISC-RELIEF)
August 1, 2024 updated by: Foundation University Islamabad
Effects of Physical Therapy on Low Back Pain, Disc Height Index, Postural Stability, Disability, Gait and Function in Persons With Postero-lateral Disc Herniation: The DISC-RELIEF Trial
The current study aims to determine if physical therapy is significantly superior in improving postural stability, pain and function and disc height index in persons with discogenic low back pain, as compared to the standardized medical treatment.
Study Overview
Status
Enrolling by invitation
Conditions
Study Type
Interventional
Enrollment (Estimated)
42
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Federal
-
Islamabad, Federal, Pakistan
- Foundation University Islamabad
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Both male and female participants
- Postero-lateral lumbar disc herniation
- Aged 18-50 years old
- Low back pain intensity less than 80/100mm on visual analogue scale or 8/10 on numeric pain rating scale
- Positive peripheralization and centralization phenomenon
Exclusion Criteria:
- Individuals with and any musculoskeletal, metabolic, or neurological disorders that may impair gait, postural stability or sensory integrity will be excluded from the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Control Group
The Control group will receive standard treatment for the management of discogenic low back pain.
|
Standard medical treatment
|
|
Experimental: Experimental Group
The Physical Therapy group will receive Physical Therapy for the management of discogenic low back pain.
|
Lumbar traction using traction table
Mckenzie Extension Exercises
Interferential Therapy for 20 minutes
Heat Therapy for 20 minutes
3-5 reptations of Mulligan's lumbar extension Sustained Natural Apophyseal Glides (SNAGs)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Back Pain
Time Frame: 2 weeks
|
Pain will be measured via Visual Analogue Scale.
A higher score signifies poor outcome.
|
2 weeks
|
|
Postural Stability
Time Frame: 2 weeks
|
Postural Stability will be measured via Biodex Balance System.
A higher score signifies poor outcome.
|
2 weeks
|
|
Lumbar Range of Motion
Time Frame: 2 weeks
|
Lumbar Range of Motion will be measured via inclinometer.
A higher score signifies good outcome.
|
2 weeks
|
|
Stride length
Time Frame: 2 weeks
|
Stride length during gait will be analyzed using observational gait analysis.
A greater stride length signifies better outcome
|
2 weeks
|
|
Lumbar Disability
Time Frame: 2 weeks
|
Lumbar Disability will be measured via Oswestry Disability Index.
|
2 weeks
|
|
Gait Velocity
Time Frame: 2 weeks
|
Velocity during gait will be analyzed using observational gait analysis.
A greater gait velocity signifies better outcome
|
2 weeks
|
|
Cadence
Time Frame: 2 weeks
|
Cadence during gait will be analyzed using observational gait analysis, which is number of steps per minute.
|
2 weeks
|
|
Disc height index
Time Frame: 2 weeks
|
Disc height index will be analyzed using Magnetic Resonance Imaging.
A greater disc height index signifies better outcome
|
2 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Muhammad Osama, PhD*, Foundation University Islamabad
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
August 7, 2024
Primary Completion (Estimated)
February 7, 2025
Study Completion (Estimated)
February 7, 2025
Study Registration Dates
First Submitted
July 30, 2024
First Submitted That Met QC Criteria
August 1, 2024
First Posted (Actual)
August 2, 2024
Study Record Updates
Last Update Posted (Actual)
August 2, 2024
Last Update Submitted That Met QC Criteria
August 1, 2024
Last Verified
July 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FUI/CTR/2024/16
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.